Operator
Good day, and thank you for standing by. Welcome to the SeaStar Medical Reports Second Quarter 2026 Financial Results.
[Operator Instructions]
Please be advised that today’s conference is being recorded.
[Operator Instructions]
I would now like to hand the conference over to your speaker today, Jackie Cossmon.
Jackie Cossmon
Thank you, Josh. Good afternoon, and thank you for joining the SeaStar Medical Second Quarter 2026 Financial Results Conference Call. I’m Jackie Cossmon with Wheelhouse Life Science Advisors. Joining me from SeaStar Medical today are Eric Schlorff, Chief Executive Officer; Tim Varacek, Senior Vice President of Commercial and Business Operations; Dr. Kevin Chung, Chief Medical Officer; and Mike Messinger, Chief Financial Officer.
I would like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of federal securities laws. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any anticipated results. For a list and description of these risks and uncertainties, please review SeaStar Medical’s filings with the Securities and Exchange Commission.
Furthermore, the content of this conference call contains information that is accurate only as of the date of the live broadcast, August 12, 2026. SeaStar Medical undertakes no obligation to revise or update any statements to reflect events or circumstances, except as required by law.
And now I’d like to turn the call over to Eric. Eric?
